{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:14:14Z","timestamp":1789085654801,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-026-01231-4","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:26:24Z","timestamp":1782458784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Disulfidptosis-related signatures identify SPARC+\/CYR61+ stromal cells mediating immunosuppression in gastric cancer"],"prefix":"10.1007","volume":"49","author":[{"given":"Yuxuan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianming","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"1231_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"F. Bray et al., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024)","journal-title":"CA Cancer J. Clin."},{"key":"1231_CR2","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/cncr.33587","volume":"127","author":"F Bray","year":"2021","unstructured":"F. Bray, M. Laversanne, E. Weiderpass, I. Soerjomataram, The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 127, 3029\u20133030 (2021)","journal-title":"Cancer"},{"key":"1231_CR3","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(25)00052-2","volume":"405","author":"R Sundar","year":"2025","unstructured":"R. Sundar et al., Gastric cancer. Lancet. 405, 2087\u20132102 (2025)","journal-title":"Lancet"},{"key":"1231_CR4","first-page":"264","volume":"71","author":"SS Joshi","year":"2021","unstructured":"S.S. Joshi, B.D. Badgwell, Current treatment and recent progress in gastric cancer. CA Cancer J. Clin. 71, 264\u2013279 (2021)","journal-title":"CA Cancer J. Clin."},{"key":"1231_CR5","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1053\/j.gastro.2015.05.059","volume":"149","author":"P Tan","year":"2015","unstructured":"P. Tan, K.G. Yeoh, Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma. Gastroenterology. 149, 1153\u20131162e3 (2015)","journal-title":"Gastroenterology"},{"key":"1231_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Comprehensive molecular","year":"2014","unstructured":"Comprehensive molecular, characterization of gastric adenocarcinoma. Nature. 513, 202\u2013209 (2014)","journal-title":"Nature"},{"key":"1231_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.tcb.2023.07.009","volume":"34","author":"X Liu","year":"2024","unstructured":"X. Liu, L. Zhuang, B. Gan, Disulfidptosis: disulfide stress-induced cell death. Trends Cell. Biol. 34, 327\u2013337 (2024)","journal-title":"Trends Cell. Biol."},{"key":"1231_CR8","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","volume":"25","author":"X Liu","year":"2023","unstructured":"X. Liu et al., Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis. Nat. Cell. Biol. 25, 404\u2013414 (2023)","journal-title":"Nat. Cell. Biol."},{"key":"1231_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13046-023-02712-2","volume":"42","author":"T Zheng","year":"2023","unstructured":"T. Zheng, Q. Liu, F. Xing, C. Zeng, W. Wang, Disulfidptosis: a new form of programmed cell death. J. Exp. Clin. Cancer Res. 42, 137 (2023)","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1231_CR10","doi-asserted-by":"publisher","first-page":"13995","DOI":"10.1007\/s00432-023-05211-1","volume":"149","author":"Y Li","year":"2023","unstructured":"Y. Li, M. Tang, W. Dang, S. Zhu, Y. Wang, Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in colorectal cancer. J. Cancer Res. Clin. Oncol. 149, 13995\u201314014 (2023)","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"1231_CR11","doi-asserted-by":"publisher","first-page":"107402","DOI":"10.1016\/j.compbiomed.2023.107402","volume":"165","author":"J Huang","year":"2023","unstructured":"J. Huang et al., Identification of a disulfidptosis-related genes signature for prognostic implication in lung adenocarcinoma. Comput. Biol. Med. 165, 107402 (2023)","journal-title":"Comput. Biol. Med."},{"key":"1231_CR12","doi-asserted-by":"publisher","first-page":"1198878","DOI":"10.3389\/fimmu.2023.1198878","volume":"14","author":"H Chen","year":"2023","unstructured":"H. Chen, W. Yang, Y. Li, L. Ma, Z. Ji, Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients. Front. Immunol. 14, 1198878 (2023)","journal-title":"Front. Immunol."},{"key":"1231_CR13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s40001-023-01535-3","volume":"28","author":"J Zhao","year":"2023","unstructured":"J. Zhao et al., Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinoma. Eur. J. Med. Res. 28, 571 (2023)","journal-title":"Eur. J. Med. Res."},{"key":"1231_CR14","doi-asserted-by":"publisher","first-page":"1294677","DOI":"10.3389\/fimmu.2023.1294677","volume":"14","author":"T Yang","year":"2023","unstructured":"T. Yang et al., Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies. Front. Immunol. 14, 1294677 (2023)","journal-title":"Front. Immunol."},{"key":"1231_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10495-023-01900-x","volume":"29","author":"C Zhang","year":"2024","unstructured":"C. Zhang et al., Development and experimental validation of a machine learning-based disulfidptosis-related ferroptosis score for hepatocellular carcinoma. Apoptosis. 29, 103\u2013120 (2024)","journal-title":"Apoptosis"},{"key":"1231_CR16","doi-asserted-by":"publisher","first-page":"1204338","DOI":"10.3389\/fimmu.2023.1204338","volume":"14","author":"Z Wang","year":"2023","unstructured":"Z. Wang et al., Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma. Front. Immunol. 14, 1204338 (2023)","journal-title":"Front. Immunol."},{"key":"1231_CR17","doi-asserted-by":"publisher","first-page":"620","DOI":"10.7150\/thno.60540","volume":"12","author":"X Li","year":"2022","unstructured":"X. Li et al., Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer. Theranostics. 12, 620\u2013638 (2022)","journal-title":"Theranostics"},{"key":"1231_CR18","doi-asserted-by":"publisher","first-page":"105785","DOI":"10.1016\/j.phrs.2021.105785","volume":"171","author":"H Zhang","year":"2021","unstructured":"H. Zhang et al., The distinct roles of exosomes in tumor-stroma crosstalk within gastric tumor microenvironment. Pharmacol. Res. 171, 105785 (2021)","journal-title":"Pharmacol. Res."},{"key":"1231_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41385-019-0227-4","volume":"13","author":"O Pabst","year":"2020","unstructured":"O. Pabst, E. Slack, IgA and the intestinal microbiota: the importance of being specific. Mucosal Immunol. 13, 12\u201321 (2020)","journal-title":"Mucosal Immunol."},{"key":"1231_CR20","doi-asserted-by":"crossref","unstructured":"J.M. Woof, M.A. Kerr, The function of immunoglobulin A in immunity. J Pathol. 208, 270\u2009\u2013\u200982 (2006)","DOI":"10.1002\/path.1877"},{"key":"1231_CR21","doi-asserted-by":"crossref","unstructured":"P. Ferraboschi, S. Ciceri, P. Grisenti, Applications of lysozyme, an innate immune defense factor, as an alternative antibiotic. Antibiot. (Basel) 10(2021)","DOI":"10.3390\/antibiotics10121534"},{"key":"1231_CR22","doi-asserted-by":"publisher","first-page":"10040","DOI":"10.1038\/s41598-022-14319-2","volume":"12","author":"J Chen","year":"2022","unstructured":"J. Chen et al., Integrated analysis reveals the pivotal interactions between immune cells in the melanoma tumor microenvironment. Sci. Rep. 12, 10040 (2022)","journal-title":"Sci. Rep."},{"key":"1231_CR23","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13578-023-01034-2","volume":"13","author":"F Dong","year":"2023","unstructured":"F. Dong, P. Ping, S.Q. Wang, Y. Ma, X.F. Chen, Identification and validation of CCL2 as a potential biomarker relevant to mast cell infiltration in the testicular immune microenvironment of spermatogenic dysfunction. Cell. Biosci. 13, 94 (2023)","journal-title":"Cell. Biosci."},{"key":"1231_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12943-025-02226-9","volume":"24","author":"L Luo","year":"2025","unstructured":"L. Luo et al., Single-cell RNA sequencing identifies molecular biomarkers predicting late progression to CDK4\/6 inhibition in patients with HR+\/HER2- metastatic breast cancer. Mol. Cancer. 24, 48 (2025)","journal-title":"Mol. Cancer"},{"key":"1231_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.drup.2008.08.005","volume":"11","author":"IT Tai","year":"2008","unstructured":"I.T. Tai, M.J. Tang, SPARC in cancer biology: its role in cancer progression and potential for therapy. Drug Resist. Updat. 11, 231\u2013246 (2008)","journal-title":"Drug Resist. Updat"},{"key":"1231_CR26","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1007\/s00018-011-0778-3","volume":"68","author":"LF Lau","year":"2011","unstructured":"L.F. Lau, CCN1\/CYR61: the very model of a modern matricellular protein. Cell. Mol. Life Sci. 68, 3149\u20133163 (2011)","journal-title":"Cell. Mol. Life Sci."},{"key":"1231_CR27","doi-asserted-by":"publisher","first-page":"1753274","DOI":"10.3389\/fimmu.2026.1753274","volume":"17","author":"F Lyu","year":"2026","unstructured":"F. Lyu et al., Sphingolipid-associated signature unveils TIMP1-driven temozolomide resistance and guides stratified therapy in glioblastoma. Front. Immunol. 17, 1753274 (2026)","journal-title":"Front. Immunol."},{"key":"1231_CR28","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"I. Korsunsky et al., Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods. 16, 1289\u20131296 (2019)","journal-title":"Nat. Methods"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01231-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01231-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01231-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:57:26Z","timestamp":1789084646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-026-01231-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1231"],"URL":"https:\/\/doi.org\/10.1007\/s13402-026-01231-4","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"114"}}